Greg Pyszczymuka

Corporate Officer/Principal bei AYTU BIOPHARMA, INC.

Vermögen: 71 719 $ am 31.05.2024

Health Technology

Consumer Services

Aktive Positionen von Greg Pyszczymuka

Unternehmen	Position	Beginn	Ende
AYTU BIOPHARMA, INC.	Corporate Officer/Principal	01.01.2022	-

Unternehmen	Position	Beginn	Ende
NEOS THERAPEUTICS, INC.	Corporate Officer/Principal	01.11.2018	31.03.2021

Rutgers State University of New Jersey	Undergraduate Degree
Argosy University	Masters Business Admin

International

Vereinigte Staaten	4
Frankreich	2

Operativ

Corporate Officer/Principal	2
Undergraduate Degree	1
Masters Business Admin	1

Sektoral

Health Technology	3
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
AYTU BIOPHARMA, INC.	Health Technology

Private Unternehmen	1
Neos Therapeutics, Inc. Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX.	Health Technology

Private Unternehmen

Health Technology